US OptionsDetailed Quotes
REKR240719C1000
- 0.65
- 0.000.00%
15min DelayClose Jun 24 15:25 ET
0.00High0.00Low
0.65Open0.65Pre Close0 Volume1 Open Interest1.00Strike Price0.00Turnover165.50%IV-5.17%PremiumJul 19, 2024Expiry Date0.74Intrinsic Value100Multiplier14DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9684Delta0.1244Gamma2.32Leverage Ratio-0.0015Theta0.0004Rho2.25Eff Leverage0.0002Vega
Rekor Systems Stock Discussion
Sign in to post a comment
$Rekor Systems(REKR.US$
NEWS
Rekor Systems Awarded Patent for Privacy-Enhanced Traffic Management Technology for Roadway Intelligence
NEWS
Rekor Systems Awarded Patent for Privacy-Enhanced Traffic Management Technology for Roadway Intelligence
$Rekor Systems(REKR.US$ how low it can go?
$Rekor Systems(REKR.US$ what a freaking joke
2
I have noticed recently that some shares despite FDA approval, price action is opposite, also earning call sometimes when it beats estimates projection, the market sentiment or price action is in reverse.
Which is more important when picking a trade:
Earning or FDA outcome
Acquisition or Market sentiment
Happy to learn from friends here.
$Enlivex Therapeutics(ENLV.US$
$Akebia Therapeutics(AKBA.US$
$Rekor Systems(REKR.US$
$OncoCyte(OCX.US$
Which is more important when picking a trade:
Earning or FDA outcome
Acquisition or Market sentiment
Happy to learn from friends here.
$Enlivex Therapeutics(ENLV.US$
$Akebia Therapeutics(AKBA.US$
$Rekor Systems(REKR.US$
$OncoCyte(OCX.US$
1
2
$Akebia Therapeutics(AKBA.US$
I am seeing a similar trend with $Rekor Systems(REKR.US$
Shorties will keep it down for ever.
Will average down on this. What do you think guys?
I am seeing a similar trend with $Rekor Systems(REKR.US$
Shorties will keep it down for ever.
Will average down on this. What do you think guys?
2
4
$Rekor Systems (REKR.US)$ all good news for rekor but yet the stock price is tanking. such bullshit
3
$Rekor Systems(REKR.US$ time to buy!!!
1
Rekor Systems' high P/S ratio is likely due to investors' expectations of continued strong revenue performance. The potential for a deterioration in revenues is seen as remote, justifying the elevated P/S ratio.
1
No comment yet
Matt the Man : still losing money no matter what